- TWD10.27bn
- TWD9.79bn
- TWD15.94bn
- 52
- 60
- 52
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16,996 | 15,179 | 15,525 | 17,078 | 15,941 |
Cost of Revenue | |||||
Gross Profit | 4,740 | 4,775 | 4,189 | 4,315 | 3,844 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 17,381 | 15,099 | 15,355 | 16,525 | 15,815 |
Operating Profit | -385 | 80.2 | 170 | 553 | 126 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -290 | 1,497 | 395 | 458 | 861 |
Provision for Income Taxes | |||||
Net Income After Taxes | -442 | 1,311 | 318 | 260 | 698 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -508 | 1,240 | 239 | 109 | 568 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -508 | 1,240 | 239 | 109 | 568 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.847 | 2.06 | 0.376 | 0.182 | 0.946 |
Dividends per Share | |||||
Special Dividends per Share |